Paraneoplastic syndromes: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: {{subpages}} <!-- Text is transcluded from the BASEPAGENAME/Definition subpage-->) |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
< | {{TOC|right}} | ||
'''Paraneoplastic syndromes''' are a group of metabolic and neurologic disorders resulting from remote [[neoplasm]]s, but are not themselves cancers. They appear to be caused by [[cytokines]] release either from the tumors themselves, or from [[T-lymphocytes]], or by [[antibody|antibodies]] characteristic of [[autoimmune disease]]. | |||
==Laboratory diagnosis== | |||
A paraneoplastic antibody screen panel, for example, can consist of:<ref>{{citation | |||
| url = http://www.questdiagnostics.com/hcp/testmenu/jsp/showTestMenu.jsp?fn=10996X.html&labCode=SJC | |||
| publisher = Quest Diagnostics | |||
| title = Paraneoplastic Syndrome Antibody Panel w/Reflex to Western Blot and Titer }}</ref> | |||
* Neuronal Nuclear Antibody (Hu) Screen, Serum | |||
* Neuronal Nuclear Antibody Screen, Ri | |||
* Neuronal Nuclear Antibody Titer, Serum | |||
* Neuronal Nuclear Antibody, Ri, Titer | |||
* Neuronal Nuclear Antibody, Ri, Western Blot | |||
* Neuronal Nuclear Antibody, Western Blot, Serum | |||
* Purkinje Cell (Yo) Antibody Screen, IFA, Serum | |||
* Purkinje Cell Antibody Titer, IFA, Serum | |||
==Metabolic== | |||
[[Fever]] is the most common manifestation.<ref name=eMed-Intro>{{citation | |||
| http://emedicine.medscape.com/article/280744-overview | |||
| journal = eMedicine | |||
| title = Paraneoplastic syndromes: overview | |||
| author = ALuigi Santacroce, Laura Diomede, Silvia Gagliardi, Lodovico Balducci | |||
| date = 21 February 2010}}</ref> [[Cachexia]], with or without loss of appetite, is common. | |||
==Rheumatologic== | |||
An assortment of rheumatologic disorders may precede or accompany the neoplasm: <ref name=eMed-Intro/> | |||
*[[Scleroderma]] often precedes a cancer diagnosis. | |||
**Its widespread form is typical of malignancies of the breast, uterus, and lung (both alveolar and bronchial forms). | |||
**The localized form is characteristic of carcinoids and of lung tumors (bronchoalveolar forms). | |||
* arthropathies arise as rheumatic polyarthritis or [[polymyalgia]], particularly in patients with myelomas; lymphomas; acute leukemia; malignant histiocytosis; and tumors of the colon, pancreas, prostate, and CNS | |||
*Hypertrophic osteoarthropathy may be observed in patients with lung cancers, pleural mesothelioma, or phrenic neurilemmoma. | |||
*Systemic lupus erythematosus (SLE) may develop in patients with lymphomas or cancers of the lung, breast, or gonads. | |||
*Secondary amyloidosis of the connective tissues is a rare presentation in patients with myeloma, renal carcinoma, and lymphomas. | |||
==Neurologic== | |||
The linkage between cancer and neurologic disorder was first reported in 1890 <ref>Auche M. Des nevrites peripheriques chez les cancereux. Rev Med. 1890;10:785–807.</ref> "Neurologic symptoms generally develop over a period of days to weeks and usually occur prior to the tumor being discovered. These symptoms may include difficulty in walking or swallowing, loss of muscle tone, loss of fine motor coordination, slurred speech, memory loss, vision problems, sleep disturbances, dementia, seizures, sensory loss in the limbs, and vertigo or dizziness. Paraneoplastic syndromes include [[Lambert-Eaton myasthenic syndrome]], [[stiff-person syndrome]], [[encephalomyelitis]], [[myasthenia gravis]], [[cerebellar degeneration]], limbic or brainstem encephalitis, [[neuromyotonia]], [[opsoclonus]], and sensory neuropathy." <ref>{{citation | |||
| url = http://www.ninds.nih.gov/disorders/paraneoplastic/paraneoplastic.htm | |||
| title = Paraneoplastic disorders information page | |||
| publisher = National Institute of Neurological Disorders and Stroke, [[National Institutes of Health]]}}</ref> | |||
==References== | |||
{{reflist}}[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 11:01, 1 October 2024
Paraneoplastic syndromes are a group of metabolic and neurologic disorders resulting from remote neoplasms, but are not themselves cancers. They appear to be caused by cytokines release either from the tumors themselves, or from T-lymphocytes, or by antibodies characteristic of autoimmune disease.
Laboratory diagnosis
A paraneoplastic antibody screen panel, for example, can consist of:[1]
- Neuronal Nuclear Antibody (Hu) Screen, Serum
- Neuronal Nuclear Antibody Screen, Ri
- Neuronal Nuclear Antibody Titer, Serum
- Neuronal Nuclear Antibody, Ri, Titer
- Neuronal Nuclear Antibody, Ri, Western Blot
- Neuronal Nuclear Antibody, Western Blot, Serum
- Purkinje Cell (Yo) Antibody Screen, IFA, Serum
- Purkinje Cell Antibody Titer, IFA, Serum
Metabolic
Fever is the most common manifestation.[2] Cachexia, with or without loss of appetite, is common.
Rheumatologic
An assortment of rheumatologic disorders may precede or accompany the neoplasm: [2]
- Scleroderma often precedes a cancer diagnosis.
- Its widespread form is typical of malignancies of the breast, uterus, and lung (both alveolar and bronchial forms).
- The localized form is characteristic of carcinoids and of lung tumors (bronchoalveolar forms).
- arthropathies arise as rheumatic polyarthritis or polymyalgia, particularly in patients with myelomas; lymphomas; acute leukemia; malignant histiocytosis; and tumors of the colon, pancreas, prostate, and CNS
- Hypertrophic osteoarthropathy may be observed in patients with lung cancers, pleural mesothelioma, or phrenic neurilemmoma.
- Systemic lupus erythematosus (SLE) may develop in patients with lymphomas or cancers of the lung, breast, or gonads.
- Secondary amyloidosis of the connective tissues is a rare presentation in patients with myeloma, renal carcinoma, and lymphomas.
Neurologic
The linkage between cancer and neurologic disorder was first reported in 1890 [3] "Neurologic symptoms generally develop over a period of days to weeks and usually occur prior to the tumor being discovered. These symptoms may include difficulty in walking or swallowing, loss of muscle tone, loss of fine motor coordination, slurred speech, memory loss, vision problems, sleep disturbances, dementia, seizures, sensory loss in the limbs, and vertigo or dizziness. Paraneoplastic syndromes include Lambert-Eaton myasthenic syndrome, stiff-person syndrome, encephalomyelitis, myasthenia gravis, cerebellar degeneration, limbic or brainstem encephalitis, neuromyotonia, opsoclonus, and sensory neuropathy." [4]
References
- ↑ Paraneoplastic Syndrome Antibody Panel w/Reflex to Western Blot and Titer, Quest Diagnostics
- ↑ 2.0 2.1 ALuigi Santacroce, Laura Diomede, Silvia Gagliardi, Lodovico Balducci (21 February 2010), "Paraneoplastic syndromes: overview", eMedicine
- ↑ Auche M. Des nevrites peripheriques chez les cancereux. Rev Med. 1890;10:785–807.
- ↑ Paraneoplastic disorders information page, National Institute of Neurological Disorders and Stroke, National Institutes of Health